PMC5949173_01
Pelvic MRI at diagnosis (axial view).
CRIHEM2018-3604298.001.jpg
PMC5949173_01_CRIHEM2018-3604298.001.jpg
fig1
Magnetic resonance imaging (MRI) of the pelvis with contrast, performed two weeks after PET-CT, demonstrated a 2.3 cm lesion in the central zone at the base of the prostate with concern for the surrounding tissue invasion (Figure 1).
Pelvic MRI after treatment (axial view).
CRIHEM2018-3604298.002.jpg
PMC5949173_01_CRIHEM2018-3604298.002.jpg
fig2
He subsequently received three cycles of consolidation chemotherapy with intermediate-dose cytarabine; serial imaging during treatments showed continuous response without complete resolution of the prostate lesion (Figure 2).